alpelisib,fulvestrant
novartis
['fulv', 'biomarker', 'bcsm', 'breast', 'alpelisib']
biomarker analysis confirms benefit of alpelisib plus fulvestrant regardless of mutation status in hr+/her- breast cancer #asco22 #bcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.